Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Rajwant Sodhi Biography and Net Worth

Insider of ResMed

Raj Sodhi was appointed president of ResMed’s software as a service (SaaS) business in July 2017. He was previously president of the global Healthcare Informatics (HI) team, leading the development of ResMed’s HI solutions and ResMed itself to its current standing as a global digital health leader, with an expanding portfolio of device- and SaaS-based offerings. He joined ResMed in 2012 through the acquisition of Umbian Inc. of which he was co-founder and president.

Before ResMed and Umbian, Raj worked in the financial services industry, designing, developing and managing SaaS solutions. He was senior vice president of Business Development and chief technology officer for Skipjack Financial Services from 2005 to 2009, and co-founder and chief technology officer of TransActive Ecommerce Solutions from 2000 to 2005.

Raj currently sits on the board of Tandem Diabetes Care (NASDAQ: TNDM), a medical device company specializing in insulin delivery for people with diabetes.

Raj holds a Master of Business Administration and a Bachelor of Science in mathematics and statistics from Dalhousie University in Halifax, Nova Scotia.

What is Rajwant Sodhi's net worth?: The estimated net worth of Rajwant Sodhi is at least $6.20 million as of July 1st, 2021. Mr. Sodhi owns 25,665 shares of ResMed stock worth more than $6,199,381 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Sodhi may own. Learn More about Rajwant Sodhi's net worth.
How do I contact Rajwant Sodhi?: The corporate mailing address for Mr. Sodhi and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Rajwant Sodhi's contact information.
Has Rajwant Sodhi been buying or selling shares of ResMed?: Rajwant Sodhi has not been actively trading shares of ResMed during the last ninety days. Most recently, Rajwant Sodhi sold 1,500 shares of the business's stock in a transaction on Thursday, July 1st. The shares were sold at an average price of $245.72, for a transaction totalling $368,580.00. Following the completion of the sale, the insider now directly owns 25,665 shares of the company's stock, valued at $6,306,403.80. Learn More on Rajwant Sodhi's trading history.
Who are ResMed's active insiders?: ResMed's insider roster includes Carol Burt (Director), Jan De Witte (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.
Are insiders buying or selling shares of ResMed?: In the last twelve months, insiders at the medical equipment provider sold shares 27 times. They sold a total of 187,789 shares worth more than $41,061,987.20. The most recent insider tranaction occured on November, 12th when Director Witte Jan De sold 796 shares worth more than $198,052.76. Insiders at ResMed own 0.7% of the company. Learn More about insider trades at ResMed.
Information on this page was last updated on 11/12/2024.

Rajwant Sodhi Insider Trading History at ResMed

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/1/2021	Sell	1,500	$245.72	$368,580.00	25,665
4/1/2021	Sell	1,500	$194.14	$291,210.00	30,088
3/1/2021	Sell	1,500	$194.34	$291,510.00	31,588
2/1/2021	Sell	1,500	$203.76	$305,640.00	33,088
11/2/2020	Sell	1,500	$195.16	$292,740.00	31,089
10/1/2020	Sell	1,500	$172.84	$259,260.00	32,589
9/1/2020	Sell	1,500	$181.00	$271,500.00	34,089
8/3/2020	Sell	1,500	$200.06	$300,090.00
7/1/2020	Sell	1,500	$189.49	$284,235.00	89,874
5/1/2020	Sell	1,500	$164.00	$246,000.00	32,670
11/1/2019	Sell	1,350	$144.38	$194,913.00
2/25/2019	Sell	16,739	$101.50	$1,699,008.50	25,639

Rajwant Sodhi Buying and Selling Activity at ResMed

ResMed Company Overview

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Today's Range

Now: $242.35

$240.68

$242.75

50 Day Range

MA: $242.10

$231.43

$256.07

2 Week Range

Now: $242.35

$151.95

$260.49

Volume

133,638 shs

Average Volume

1,039,862 shs

Market Capitalization

$35.58 billion

P/E Ratio

32.10

Dividend Yield

0.89%

Beta

0.69

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad